Moretus — published investment ideas

Beyond consensus,
on the record.

About twelve times a year we finish months of work on one idea — equities, crypto, macro, a mispricing wherever it sits — and send every member the full note at the same moment: the facts, our view, and what would prove us wrong. When we hold a position, page one says so.

Every idea announced the day it publishes. The name, 30 days later. Free:

Ready for the full research? Membership →

The aim is alpha. Check the tape — the record is public and dated:

Including the ones that ended badly. The archive here will hold us to the same standard.

[01] The product

One idea, taken seriously.

Written to be acted on, not skimmed. Each note is a single idea:

Where consensus sits, and why we think it’s wrong
The asymmetry — what’s priced in versus what we expect, and what would prove us wrong
Our conclusion — act, watch, or walk away — and any position we hold, disclosed on page one

See the ideas we’ve published →

[02] How it works

Months on one idea

Cross-asset and uncorrelated by design — equities, crypto, macro, prediction markets. Fundamentals first, overlaid with the demographic and alternative-data signals our own pipeline surfaces.

A conclusion, not a rating

Own it at this price, wait for the trigger, or walk away. We don’t run coverage and we don’t maintain ratings — the note is finished, and any position we hold is disclosed on page one.

The decision stays yours

One send, all members at the same moment — no tiers, no early access. We bring facts and a view beyond consensus; you make the call, and the sizing.

[03] Membership

Every idea we publish. €1,000.

Pay once — founding members get every idea for life. 150 seats. After seat 150, membership is €1,000 a year.

150 of 150 founding seats remain

Become a founding member

[04] Questions

What do I get?: Every research note we publish — about twelve a year — delivered by email the moment it’s finished, plus the full archive.
What kinds of ideas?: Wherever our data gives us an edge: mostly equities, but also crypto, macro, and asymmetries surfaced by alternative data or prediction markets. Cross-sector and uncorrelated to any benchmark, by design.
Do you buy every idea you publish?: No — the research decides. Some notes end in a position, some in a watchlist trigger, some in a pass. Forcing a trade out of every note is how research shops go bad. When we do hold a position, page one says so.
Do you signal when you buy or sell?: No. Disclosure tells you where we stand on the day a note publishes — after that we don’t run alerts, exits, or a model portfolio. The research is the product; the decisions are yours.
Is this investment advice?: No. We publish the same research to every member at the same time and never advise anyone individually. Any position we hold is disclosed on the note itself.
Why lifetime, then annual?: The first 150 members are backing this before the archive can speak for itself — lifetime access is what that’s worth to us. From seat 151, membership is annual, permanently.
What if an idea goes against us?: It stays in the archive with everything else. We never delete a miss — the archive is complete or it’s worthless.
What’s in the free emails?: The day an idea publishes: that it exists, and its shape — sector, size, direction. Thirty days later: the name and the public thesis. The full research note is members-only, always.

Members read it first.